GeneVentiv Therapeutics
Raleigh, US · Founded 2020
Biotech
Founders & leadership
RL
Richard LimehouseDirector
DR
Damon RaceExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$1.4MraisedAug 2022 · 1 investors · BiotechnologyRule 506(b)
▶$1.4MraisedAug 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard LimehouseDirector
- Damon RaceExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.4M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.